Speaker illustration

Doctor Wen Sun

The Chinese University of Hong Kong, Shatin (Hong Kong)

Member of:

European Society of Cardiology

10-year trends in oral anticoagulation therapies and ischemic stroke among 157,583 patients with non-valvular atrial fibrillation

Event: ESC Congress 2023

Topic: Stroke in Atrial Fibrillation

Session: Stroke prediction and prevention in atrial fibrillation

Thumbnail

Atrial fibrillation burden and timing of anticoagulation therapy in patients with screen-detected and clinically-diagnosed AF

Event: ESC Congress 2023

Topic: Stroke in Atrial Fibrillation

Session: Stroke prediction and prevention in atrial fibrillation

Thumbnail

Impact of sodium-glucose co-transporter 2 inhibitors on cardiovascular outcomes in patients with chronic kidney disease: Hong Kong-wide, observational, propensity score matched analysis

Event: ESC Congress 2022

Topic: Renal Failure and Cardiovascular Disease

Session: Renal failure and cardiovascular disease 1

Thumbnail

Timing of initiation of sodium-glucose co-transporter 2 inhibitor in patients with diabetes and chronic cardiac failure

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Chronic heart failure and diabetes

Thumbnail

Impact of early initiation of SGLT2 inhibitor on cardiovascular outcomes in diabetic patients with known atherosclerotic cardiovascular disease or risk factors: propensity score matched analysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Can we improve outcomes by targeting metabolic risk?

Thumbnail

Potential benefits of ticagrelor plus aspirin in Chinese patients with stable coronary artery disease and diabetes

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Coronary Artery Disease (Chronic)/Chronic Coronary Syndromes ePosters

Thumbnail

Novel use of CHA2DS2VASC score to select patients to undergo repeat atrial fibrillation screening

Event: ESC Asia with APSC & AFC

Topic: Stroke Prevention

Session: Poster Session 1

Thumbnail

Adverse impact of late initiation of oral anticoagulant therapy after diagnosis of atrial fibrillation

Event: ESC Congress 2018

Topic: Stroke Prevention

Session: Atrial fibrillation - Stroke prevention

Thumbnail

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb